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Abstract
Background: Dietary fibre is both preventive and therapeutic for bowel functional diseases. Soluble cocoa
products are good sources of dietary fibre that may be supplemented with this dietary component. This study
assessed the effects of regularly consuming two soluble cocoa products (A and B) with different non-starch
polysaccharides levels (NSP, 15.1 and 22.0% w/w, respectively) on bowel habits using subjective intestinal function
and symptom questionnaires, a daily diary and a faecal marker in healthy individuals.
Methods: A free-living, two-stage, randomized, crossover, single-blind intervention was carried out in 44 healthy
men and women, between 18-55 y old, who had not taken dietary supplements,
laxatives, or antibiotics six months before the start of the study. In the four-week-long intervention stages,
separated by a three-week-wash-out stage, two servings of A and B, that provided 2.26 vs. 6.60 g/day of NSP
respectively, were taken. In each stage, volunteers’ diet was recorded using a 72-h food intake report.
Results: Regularly consuming cocoa A and B increased fibre intake, although only cocoa B significantly increased
fibre intake (p < 0.001) with respect to the non-cocoa stage. No changes in body weight were observed in either
of the 4 week interventions. With cocoa product B, the number of daily bowel movements increased (p = 0.002),
the frequency of having a bowel movement once a day increased (p = 0.009), the time to have a bowel
movement was lower (p = 0.016) as well as the feeling of constipation (p = 0.046) without inducing adverse
gastrointestinal symptoms, only flatulence increased (p = 0.019).
Conclusions: Regular consumption of the cocoa products increases dietary fibre intake to recommended levels
and product B improves bowel habits. The use of both objective and subjective assessments to evaluate the
effects of food on bowel habits is recommended.
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Background
Dietary fibre (DF) has a broad range of beneficial health
applications such as the treatment of colonic disorders,
lowering risk of heart disease, diabetes and colon cancer,
improving measures of glycaemic control and gastroin-
testinal function, etc. [1-4]. Many of these effects have
been based on short-term studies being the evidence
obtained from long term studies scarce [2-4]. Health
authorities have already approved health claims on the
benefits of DF intake and disease prevention. However,
the main body of epidemiological and experimental data
justifying the health benefits of DF derives from studies
based on fruit, vegetables and whole grain, [5] whereas
the recommended consumption of these food items is
rarely reached. The average daily intake of total DF in
Europe and the USA lies between 15 and 20 g, while the
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day and 25 g/day for men and women, respectively [6].
The new Codex definition of DF [7] acknowledges the
difference between naturally occurring carbohydrate
polymers, which are neither digested nor absorbed in the
human small intestine, and synthetic or extracted poly-
mers. There is some evidence of health benefits of
extracted and synthetic fibres in terms of lowering levels
of cardiovascular risk factors and improving measures of
glycaemic control and gastrointestinal function, although
the confirmation of clinical benefit is lacking [5]. In this
sense, if the extracted or synthetic fibre is used as a sup-
plement it is relevant to assess the effects of the food
matrix and dose of fibre used when assessing the possible
physiological benefit.
The cocoa bean has a seed coat or bran with a high
content in DF, particularly insoluble fibre [8]. The com-
position of cocoa-derived products depends on the bota-
nical variety as well as on genetic, agronomical and food
processing. In contrast to chocolate production, the
bran remains present in cocoa powder, thus being a
good source of DF [9]. Moreover, this food stuff may be
supplemented with fibre without negatively affecting its
organoleptic properties. Cocoa powder taken as a bever-
age is widely consumed in many different countries,
including Spain [10], being popular in different popula-
tion groups, particularly as part of the breakfast meal or
consumed between lunch and dinner meals.
Dietary fibre is both preventive and therapeutic for a
range of common large-bowel functional diseases. Insolu-
ble fibre polysaccharides increase stool bulk, shorten gut
transit time and retain moisture in the faecal stream as a
consequence of being only partially fermented by the colo-
nic microbiota. On the other hand, soluble fibres are read-
ily fermented but also facilitate laxation via mechanisms
involving an increase in faecal biomass excretion [11,12].
It should not be disregarded that increasing the intake of
DF has been associated with negative gastrointestinal
effects such as flatulence, diarrhoea, bloating, etc. [13,14].
In order to evaluate the extent of the physiological effects
of DF on bowel function in epidemiological studies and
therapeutic trials, self-reported symptom and bowel func-
tion questionnaires have been used [1,4,15-18] in which
subjective answers are usually positioned on a scale. How-
ever, bowel habits can be perceived in many different ways
and thus it would be interesting to contrast the subjective
data obtained with different questionnaires, as well as with
an objective assessment tool such as faecal markers, radio-
paque pellets, or to use certain questionnaires that formu-
late objective questions such as the daily diary by Bellini et
al. [19]. This evaluation is also relevant in the case of func-
tional foods rich in dietary fibre.
This study is aimed at assessing the effects of regularly
consuming two soluble cocoa products with different
contents of NSP on dietary fibre intake and gastrointest-
inal function using subjective questionnaires, an objec-
tive faecal marker and a daily diary, and to contrast the
results obtained with the different assessment tools.
Methods
Subjects
This study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all proce-
dures involving human subjects were approved by the
Clinical Research Ethics Committee of Hospital Univer-
sitario Puerta de Hierro Majadahonda in Madrid
(Spain). Volunteer recruitment was carried out through
placing advertisements in the Universidad Complutense
campus as well as through giving short talks between
lectures. The inclusion criteria was: Non-vegetarians,
non-smoker, non-pregnant, healthy men and women,
between 18 and 55 y old, not suffering from any chronic
pathology or gastrointestinal disorders or bowel
abnormalities such as: irritable bowel syndrome, Crohn’s
diseases, ulcerative colitis, chronic intestinal inflamma-
tion, chronic constipation, diarrhoea, haemorrhoids, not
suffering lactose intolerance or other food allergies.
None had taken dietary supplements, laxatives, any type
of medication that could affect gut motility or antibio-
tics six months before the start of the study. Their body
mass index was not higher than 30 kg/m
2. Fifty subjects
initially accepted to participate in the study and gave
informed written consent.
This work forms part of a larger study in which the
effects of regularly consuming the cocoa products on car-
diovascular health is assessed. The variable used to calcu-
late the power of the study was total cholesterol. A
sample size of 38 patients to take part in this crossover
intervention was calculated in order to obtain a probabil-
ity of 80% that the study will detect a treatment differ-
ence at a two sided 0.05 significance level, if the true
difference between the treatments were 10.0 units,
assuming that the within-subject standard deviation of
the response variable is 15. Studies similar to the present
work have been performed in smaller groups, 25 and 23
subjects, in Jenkins et al. [9] and Vuksan et al. [1], respec-
tively, or similar size populations [17]. Fifty subjects were
recruited in order to increase the power of the study and
account for possible abandoners.
Study design
The study is a free-living, two-stage, randomized, cross-
over, single-blind intervention. It consisted in a one-week
run-in stage and two four-week long intervention stages
(Cocoa product A and Cocoa product B) separated by a
three-week wash-out period (Non-cocoa). The trial was
held during the autumn months. Participants were ran-
domly assigned to start taking cocoa product A or B
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random numbers).
Two soluble cocoa products provided by Nutrexpa
S.L. were used: A and B containing two different levels
of total NSP: 15.09 and 22.00% (w/w), respectively.
Cocoa product B was supplemented with extracted
cocoa bran. Each serving was individually packed in
identical sealed sachets that were labelled A or B. The
two servings of A and B weighed 15 g and 30 g, respec-
tively, and provided 2.26 vs. 6.60 g/day of NSP, respec-
tively. The servings used in this study correspond to the
quantity of the product that can reasonably be expected
to be consumed in a day. Volunteers were indicated
to consume the two servings of either product daily in
200 mL of semi-skimmed milk, thus following realistic
consumption rates. The first cocoa beverage was taken
at breakfast and the second between lunch and dinner,
in order to reduce interferences with other food items
and reproduce real consumption patterns. During the
study, certain vegetables and fruits (oranges, tangerines,
apples, grapes, strawberries and any other type of berry,
beets and onions) were restricted in order to reduce
interindividual differences in DF intake. Cocoa products
A and B contained different levels of total fat: 6.2 and
3.3% (w/w), respectively (data provided by the manufac-
turer), however the amount provided with each serving
was similar (0.93 g and 0.99 g for product A and B,
respectively).
Dietary control and compliance
Subjects were asked to maintain the same dietary habits
along the study periods. Subject’s dietary intake was regu-
larly evaluated to record any possible changes in dietary
habits. Volunteers were instructed on how to fill in the
dietary records before starting the study and during the
first intervention stage. In the last week of each study per-
iod, volunteers were asked to complete a 72 hour detailed
food intake report, specifying the ingredients and amounts
of food consumed and serving weights. Compliance was
evaluated through counting the number of cocoa servings
provided to the volunteers before and after each interven-
tion stage, as well as through weekly calling the volunteers.
In order to assess dietary composition the programme Dial
(Department of Nutrition and Bromatology I, Phaculty of
Pharmacy, Universidad Complutense de Madrid) was
used.
Bowel function questionnaire, symptom diary, daily diary
questionnaires, faecal marker
The influence of consuming the soluble cocoa on gastro-
intestinal habits was assessed using two subjective ques-
tionnaires, in order to gather the maximum information
on the effect of consuming the cocoa products on bowel
function and to cross check the reproducibility of the
answers obtained. Moreover, the answers were contrasted
with a daily diary and an objective assessment tool. With
this purpose, adapted versions of the subjective bowel
function questionnaire by Griffenberg et al. [18] and the
symptom diary by Jenkins et al. [9] were used during the
last week of each stage of the study. Also the daily diary
by Bellini et al. [19] which formulates objective and
subjective questions was applied. Griffenberg et al. [18]
questionnaire was developed to determine patients’ per-
ceptions of their bowel habits prior and post surgery
(statements regarding surgery have been withdrawn in
the present study), having its content been validated. It
consists of a list of statements describing personal bowel
habits that contain a blank that must be filled in with
words: never, rarely, sometimes, frequently and always.
For statistical treatment of the results, the five apprecia-
tions have been converted into a 0-4-point scale where 0
= never, 1 = rarely, 2 = sometimes, 3 = frequently and 4
= always. Similarly, with the symptom diary a 5-point
scale was used to answer the questions, where 0 indicates
no gas, no bloating, watery, easy to pass and no pain, and
5 indicates, severe, hard or difficult, where appropriate.
In contrast, in the daily diary questionnaire, patients
were asked to record the number of bowel movements
per day and give yes/no responses. For statistical pur-
poses, the conversion of yes = 1 and no = 0 was applied,
and for all questions the mean was calculated per week.
For a more objective assessment of the effect of cocoa
consumption on intestinal transit time, on the first day
of the last week of each stage of the study the faecal
marker Brilliant Blue FCF (Warner Jenkinson Europe,
UK) [20] was administered in a capsule (50 mg) together
with a standardised breakfast consisting of two slices of
white bread and a glass of half-skimmed milk with
(intervention periods) or without cocoa (non-cocoa
stage). Volunteers were asked to record the appearance
and disappearance time of the marker in faeces since
the time the breakfast was consumed.
Physical activity and body weight
Participants were asked to maintain their usual level of
physical activity during the study. Volunteers filled in a
questionnaire before starting the study to know their
occupation and consequently the physical activity
involved. At the beginning and the end of the study physi-
cal activity was calculated using an adapted version of the
Minnesota Leisure Time Physical Activity Questionnarie
by Martínez-González et al. [21]. Total energy expenditure
from leisure time was obtained making the assumption
that 1 MET (metabolic equivalent) is approximately
1 kcal/min for a 70-kg man. Taking this conversion factor
and knowing the number of minutes that the activities
were performed per day, the data was expressed as kcal/
day. Volunteer’s body weight was measured at the
Sarriá et al. Nutrition & Metabolism 2012, 9:33
http://www.nutritionandmetabolism.com/content/9/1/33
Page 3 of 10beginning and the end of the two intervention stages
(Cocoa product A and Cocoa product B).
Cocoa fibre analysis
The NSP content of the two cocoa products was analysed
in triplicate defatted samples following the method of
Saura-Calixto et al [22] modified in our laboratory. Briefly,
to 300 mg of cocoa powder was added 0.2 mL of a pepsin
solution (Cat. No. 7190, Merck, Darmstadt, Germany)
containing 300 mg of pepsin/mL of HCl-KCl (0.05 M HCl
and 0.03 M KCl, respectively) buffer, pH 1.5. Samples
were incubated for 1 h at 40°C in a water bath with con-
stant shaking. Then, 9 mL of Tris-maleate buffer (0.1 M,
pH 6.9) was added and the pH checked. a-Amylase (1 mL
of a 120 mg/mL solution in Tris-maleate buffer; Sigma,
A-3176) was added, and the samples were incubated in a
w a t e rb a t ha t3 7 ° Cf o r1 6hw i t hc o n s t a n ts h a k i n g .S a m -
ples were centrifuged (15 min, 3000 g) and supernatants
removed. Residues were washed twice with 10 mL of dis-
tilled water and all supernatants combined. These were
transferred into dialysis tubes (12000-14000 MWCO,
Dialysis Tubing Visking, Medicell International Ltd., Lon-
don, UK), and dialysed against water for 48 h at 25°C
(water flow 7 L/h in a 43 L reservoir). Dialysates (soluble
dietary fibre, SDF) were hydrolysed with 1 M sulphuric
acid at 100°C, 90 min and NSP determined in the hydroly-
sate. The residues obtained after enzymatic hydrolysis of
samples (insoluble dietary fibre, IDF) were washed with
acetone (Panreac, 361007) and dried overnight at room
temperature, and hydrolysed with sulphuric acid (12 M
H2SO4, 1 h, 30°C, then diluted to 1 M H2SO4 100°C,
90 min with shaking). After acid hydrolysis, samples were
centrifuged (15 min, 3000 g), pellets washed twice with
distilled water, and combined supernatants collected for
NSP determination.
Uronic acids (UA) in hydrolysates from both SDF and
IDF were quantified spectrophotometrically [23] using
galacturonic acid as standard. Neutral sugars (NS) were
analysed by spectrophotometry following the method
Southgate [24]. NSP was calculated as soluble NSP +
insoluble NSP; Soluble NSP was calculated as UA + NS,
and insoluble NSP as UA + NS.
Statistical analysis
Before hypothesis testing, data were examined for nor-
mality and for non-normally distribution. The total NSP
intake was initially used as a covariate considering that it
was significantly different (p < 0.001) in the three stages
of the study and the important role that this dietary com-
ponent plays on bowel function, however as NSP effects
was not significant in the majority of the parameters stu-
died, NSP was not used as a covariate in the statistical
analysis performed. In order to determine the effects of
consuming the soluble cocoa products on dietary intake,
on daily bowel movements and on intestinal transit time,
a mixed model with repeated measures (stage) with one
factorial fixed factor (cocoa product) was applied. Results
from the symptom diary and bowel function question-
naire were studied using generalized estimating equations
with repeated measures (stage) and one fixed factor
(cocoa product). In all parameters, where there was a sig-
nificant main effect, post hoc Bonferroni tests were also
used to analyse differences between means. Statistical sig-
nificance was set at p < 0.05. Statistical analysis was
undertaken with SPSS statistical package (version 18.0).
Data are presented as means ± standard error of mean,
unless specified otherwise.
Results
Subjects
Of the fifty volunteers who enrolled in the study, for per-
sonal, health or professional reasons 6 subjects withdrew
from the study. Of the 44 volunteers remaining, 23 were
women with an average age of 25.75 y (SD 6.29) and body
mass index (BMI) of 22.2 (SD 2.42) kg/m
2 and 21 were
men with an average age of 31.50 y (SD 10.04) and BMI of
25.04 (SD 3.94) kg/m
2.
Cocoa product fibre analysis
The NSP and polyphenol composition of the two soluble
cocoa products is shown in Table 1 (n = 3). As it can be
seen, cocoa product B had a higher NSP content in com-
parison with product A. Although both cocoas were made
of mainly insoluble NSP, cocoa A was comparatively
richer than product B in soluble NSP with up to 20.74% of
the total NSP as soluble NS plus UA in comparison with
only 7.64% of soluble NSP in cocoa product B. On the
other hand cocoa product A was richer in total polyphe-
nols as compared to cocoa B.
Dietary recording and compliance
Dietary compliance during the intervention was high
according to volunteers’ reports and to the number of ser-
vings that the volunteers returned having finished the
intervention periods. Attending to the 72 hour detailed
food intake reports and to the dietary composition assess-
ment carried out with the programme Dial, the intake of
both cocoa products statistically increased energy intake
(p = 0.045) compared to when cocoa was not consumed
(Table 2). Accordingly, protein intake was significantly
lower (p < 0.001) in the non-cocoa stage compared to
cocoa product A and B stages, as well as carbohydrate
intake (p = 0.003), which was significantly lower in the
non-cocoa stage versus cocoa product A and B stages
(Table 2). The intake of DF showed significant differences
along the study (p < 0.001; Table 3). Attending to the Bon-
ferroni test, DF intake in cocoa product B stage was statis-
tically higher compared to that in the non-cocoa stage
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trast, polyphenol intake was higher in cocoa product A
and B stages, compared to the non-cocoa stage, although
these differences did not reach the level of statistical signif-
icance. Other dietary component intakes, such as total
lipids, mono, poly and saturated fatty acids, minerals, vita-
mins A, C, E, D or total carotenes, did not show significant
changes between the different stages of the study (data not
shown).
Bowel function questionnaire, symptom diary, daily diary
questionnaires, faecal marker
Attending to both the subjective bowel function (Tables 4,
5 and 6) and the symptom questionnaire (Table 7), when
product B was consumed, stool consistency (Table 7) and
the output of hard stools (Table 4) was described to be
slightly lower and accordingly soft stools slightly higher
(Table 4), although none of the differences obtained with
these three parameters were statistically significant. In
contrast, attending to the daily diary (Table 8), the percep-
tion of lumpy or hard stools was significantly higher (p =
0.042) during the cocoa product A stage.
Additionally, the time to have a bowel movement (i.e.
the duration of defecation) was significantly lower (p =
0.016) when product B was consumed (Table 6) which
is supported with the shorter (although not statistically
different) dye appearance and disappearance times
(Table 9), and the slightly higher urgency (Table 6) to
go to the toilet for a bowel movement observed with the
cocoa product richer in fibre. Accordingly, volunteers
described having a bowel movement once a day more
frequently (p = 0.009; Table 5) when the cocoa product
richer in NSP was consumed, considering themselves
less constipated (Table 6, p = 0.046). With both pro-
ducts A and B slightly less haemorrhoid problems were
reported (Table 5). It is noteworthy that the feeling of
having diarrhoea (Table 6) was significantly smaller (p =
0.043) in both cocoa product stages compared to the
non-cocoa stage.
Daily diary answers (Table 8) showed parallel results
compared to the bowel function and symptom question-
naires. With either cocoa product the number of daily
bowel movements significantly increased (p = 0.002)
compared to the non-cocoa stage and the straining at
defecation as well as the feeling of incomplete defecation
was similar in the three stages.
In summary, the significant gastrointestinal effects
associated to consuming cocoa product B were positive,
being the only significant negative effect having greater
feeling of flatulence (p = 0.019, Table 7). However this
negative perception was not supported by the answers
relative to having crampy abdominal pain, passing gas
Table 1 Non-starch polysaccharide (NSP) and polyphenol composition of the two soluble cocoa products (Mean values
(n = 3) and standard deviation (SD)
Cocoa product A (g/100 g) Cocoa product B (g/100 g)
Mean SD Mean SD
NSP composition*
Soluble NSP 3.13 1.68
Neutral sugars 2.46 0.43 0.69 0.04
Uronic acid 0.67 0.16 0.99 0.09
Insoluble NSP 11.96 20.32
Neutral sugars 10.49 0.96 19.06 1.60
Uronic acid 1.47 0.09 1.26 0.07
Total NSP 15.09 22.00
Polyphenol composition* (μg equivalent gallic acid/g) 34.04 2.28 15.75 0.67
* dry matter
Table 2 Effects of consuming the soluble cocoa products on energy, protein, carbohydrate and lipid intake (Mean
values and standard error of mean (SEM), n = 44)
Energy Intake (Kcal/day) Protein Intake (g/day) Carbohydrate Intake (g/day) Lipid Intake (g/day)
Stage Mean SEM Mean SEM Mean SEM Mean SEM
Non-cocoa 2,281.99 59.12 94.30
a 2.51 210.97 6.78 105.73 3.23
Cocoa product A 2,465.61 74.69 110.48
bc 3.47 239.41 7.88 106.17 4.49
Cocoa product B 2,558.57 97.91 117.64
c 4.29 245.04 8.61 110.89 5.56
p = 0.045 p < 0.001 p = 0.003 N.S.
Effects were studied using a mixed model with repeated measures (stage) with one factorial fixed factor (cocoa product). Where there was a significant main
effect, post hoc Bonferroni tests were also used to analyse differences between means.
a,b Mean values within a column with unlike superscript were significantly different according to Bonferroni test.
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showed significant differences.
Physical activity and body weight
Physical activity (Kcal/day expressed as mean ± standard
error of mean) tended to be lower in cocoa product A
and B stages (677.97 (SEM 68.36) and 673.62 (SEM
67.62), respectively) compared to the non-cocoa stage
(818.60 (SEM 58.61), not showing statistical differences.
Volunteer’sb o d yw e i g h td i dn o tc h a n g ea l o n gt h e
experiment with either cocoa product. Body weights
(kg) at the beginning and the end of product A inter-
vention were 67.7 (SD 13.20) and 68.0 (SD 13.22) and of
product B intervention were 68.0 (SD 13.28) and 68.3
(SD 13.27), respectively.
Discussion
This is a free-living study that showed that the regular
addition of two servings of soluble cocoa products, con-
taining 15.1 and 22.0% (w/w) of NSP, respectively, to a
Spanish diet is an efficacious alternative to increase fibre
intake to recommended levels and the product richer in
NSP (22.0%, w/w) also promotes healthier bowel habits.
The servings used in this study correspond to the quan-
tity of the product that can reasonably be expected to be
consumed. The consumption rate of two cocoa beverages
per day reproduces real conditions in the Spanish popu-
lation and may be considered moderate [[10], http://
www.cacaoychocolate.com/consumoen.html]. The only
dietary modification introduced in this study, apart from
consuming the cocoa products, was the restriction of cer-
tain fruits and vegetables. However taking into account
the restrictions, the intake of DF remained within the
range estimated in the Spanish population (16.3 - 18.4 g/
day) [25] and was similar to that in European countries
(18.5 g/day) [26]. Up to date, there is no gold standard
for fibre intake assessment being dietary food records a
well accepted alternative, particularly if the influence of
smoking, alcohol intake, gender and education is consid-
ered [27]. With this regard, volunteers who participated
in this study were non-smokers, consumed very low
amounts of alcohol and had a similar, medium-high, edu-
cation level. In the non-cocoa stage, the intake of fibre
(Table 2) was near to the lower limit of the various daily
fibre recommendations, which range from 15 to 35 g
[28]. The regular consumption of either cocoa product
improved the intake of DF with respect to the non-cocoa
stage, particularly that corresponding to cocoa product B.
The higher intake of fibre associated to consuming cocoa
product B compared to A is due both to their unlike NSP
content (22.00% vs. 15.09%, respectively) and to the dif-
ferent net quantity consumed daily of each cocoa product
(30 g of cocoa product B vs. 15 g of A) which provided
6.6 and 2.26 g/d of total NSP.
According to the bowel function and symptom ques-
tionnaires, both cocoa diets were well tolerated and volun-
teers did not describe adverse gastrointestinal symptoms
such as abdominal pain or bloating compared to the non-
cocoa period. The only negative effect described was a
higher perception of flatulence when the product richer in
Table 3 Effects of consuming the soluble cocoa products on total fibre and polyphenol intake (Mean values and
standard error of mean (SEM), n = 44)
Total Fibre Intake (g/day) Polyphenol Intake (mg/day)
Stage Mean SEM Mean SEM
Non-cocoa 17.29
a 0.71 1424.71 106.92
Cocoa product A 19.86
a 0.88 1549.90 163.32
Cocoa product B 23.91
b 0.88 1696.43 132.23
p < 0.001 N.S.
Effects were studied using a mixed model with repeated measures (stage) with one factorial fixed factor (cocoa product). Where there was a significant main
effect, post hoc Bonferroni tests were also used to analyse differences between means.
a,bMean values within a column with unlike superscript were significantly different according to Bonferroni test.
Table 4 Effects of consuming the soluble cocoa products were studied using subjective bowel function questionnaires
(Mean values and standard error of mean (SEM), n = 44)
Soft stools Hard stools Strain to have BM Pain to have BM Blood seen with BM
Stage Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Non-cocoa 1.29 0.09 2.01 0.10 1.44 0.09 0.72 0.08 0.09 0.03
Cocoa product A 1.27 0.12 2.09 0.16 1.48 0.14 0.66 0.11 0.14 0.05
Cocoa product B 1.52 0.12 1.91 0.15 1.41 0.13 0.72 0.11 0.09 0.04
N.S. N.S. N.S. N.S. N.S.
BM, bowel movement. A 4-point scale was used to answer where 0 = never, 1 = rarely, 2 = sometimes, 3 = frequently and 4 = always.
Effects were evaluated using a generalized estimating equations with repeated measures (stage) and one fixed factor (cocoa product) were applied. Where there
was a significant main effect, post hoc Bonferroni tests were also used to analyse differences between means.
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supported with the perception of passing gas during the
day, which was slightly higher in the cocoa product B
stage without reaching a statistical difference compared to
other stages. This symptom has been widely described as a
side-effect related to fibre intake [13,14]. Excepting this
result, there was a predominant positive gastrointestinal
tolerance to the fibre-rich cocoa periods which may be
attributed to the adaptation hypothesis, according to
which a continuous intake of DF relieves negative gastro-
intestinal side-effects based on the equilibrium that is
reached between the gas-producing and gas utilizing bac-
teria [29]. Other interesting outcomes associated with the
consumption of product B, was the lower perception of
producing less hard stools with lower stool consistency
without leading to the feeling of having diarrhoea. In
agreement, Castillejo et al. [17] described that a signifi-
cantly higher number of parents reported a subjective
improvement in stool consistency in their chronically con-
stipated children who consumed a supplement of cocoa
husk.
Four positive significant changes on bowel function
over time were described associated to consuming the
cocoa product richer in fibre (6.6 g/d of total NSP): a
reduced perception of being constipated, a higher record
of having a bowel movement per day, supported by an
objective higher number of daily bowel movements, and
a lower time to have the bowel movement. The higher
frequency of daily bowel movements is in agreement
with other studies. Jenkins et al. [9] obtained a signifi-
cantly higher frequency of movements per day when a
diet containing a cocoa-bran cereal (total DF 25 g/day)
was consumed for 2 weeks versus a low-fibre cereal (total
dietary fibre 5.6 g/day). Similarly, Dahl et al. [16]
d e s c r i b e dt h a tt h ea d d i t i o no fam o d e r a t ea m o u n to f
finely processed pea hull fibre to usual food (doses ran-
ging 20-26 g/day) helped to normalize and improve
bowel function in elderly subjects resulting in a signifi-
cant increase in bowel movements among other improve-
ments of clinical symptoms of constipation. Similar
effects where observed with fibre supplementation (the
doses used were “age in years plus 5 g/day”)i nc h r o n i -
cally constipated children [30].
In addition to changes in bowel function based on the
subject’s own reports recorded in the subjective question-
naires and the diary, an objective measurement of intest-
inal transit time was carried out which evaluates overall
colonic function. The reported average transit time usually
takes 5 days [31]. On one hand, we were aware that using
a faecal dye to estimate intestinal transit time presents the
limitation that transit time isi n f l u e n c e db yt h el e v e lo f
either food or fibre in the diet [32]. In order to minimize
the possible confounding effect that could be produced by
other food items consumed simultaneously with the dye,
the dye capsule was administered with a standardised
fibre-free breakfast, formed by two slices of white bread
and semi-skimmed milk which was administered in each
of the stages of the study. Additionally, the dye was
Table 5 Effects of consuming the soluble cocoa products were studied using a subjective bowel function questionnaire
(Mean values and standard error of mean (SEM), n = 44)
Feel bowel completely
empty
Have BM once per
day
Pass gas during
day
Have crampy abdominal
pain
Have haemorrhoid
problems
Stage Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Non-cocoa 2.67 0.10 2.93
a 0.10 2.14 0.09 1.20 0.08 0.39 0.06
Cocoa product A 2.73 0.11 3.09
a 0.13 2.07 0.15 1.09 0.11 0.32 0.08
Cocoa product B 2.75 0.12 3.27
a 0.11 2.32 0.14 1.27 0.12 0.34 0.09
N.S. p = 0.009 N.S. N.S. N.S.
BM, bowel movement. A 4-point scale was used to answer where 0 = never, 1 = rarely, 2 = sometimes, 3 = frequently and 4 = always.
Effects were evaluated using a generalized estimating equations with repeated measures (stage) and one fixed factor (cocoa product) were applied. Where there
was a significant main effect, post hoc Bonferroni tests were also used to analyse differences between means.
Table 6 Effects of consuming the soluble cocoa products were studied using a subjective bowel function questionnaire
(Mean values and standard error of mean (SEM), n = 44)
Have diarrhoea Urgency to go to toilet for BM Consider myself constipated Time to have BM* (min)
Stage Mean SEM Mean SEM Mean SEM Mean SEM
Non-cocoa 1.00
a 0.07 3.28 0.08 1.34
a 0.10 0.99
a 0.10
Cocoa product A 0.79
a 0.10 3.27 0.11 1.36
a 0.14 0.98
a 0.11
Cocoa product B 0.77
a 0.09 3.43 0.09 1.16
a 0.13 0.79
a 0.13
p = 0.043 N.S. p = 0.046 p = 0.016
BM, bowel movement. A 4-point scale was used to answer where 0 = never, 1 = rarely, 2 = sometimes, 3 = frequently and 4 = always.
Effects were evaluated using generalized estimating equations with repeated measures (stage) and one fixed factor (cocoa product) were applied. Where there
was a significant main effect, post hoc Bonferroni tests were also used to analyse differences between means. * Time to have BM = duration of defecation.
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Page 7 of 10consumed on one of the days in which the 72-h food
record was filled out, so volunteers’ food intake was
recorded. In this sense, no differences in DF consumption
were observed between the three days in each stage (data
not shown). On the other hand, the advantages of using
brilliant blue are that it is non-invasive, compared to other
dyes its differentiation is quite unequivocal, and it does
not require stool collection [33]. Our results are in agree-
ment with the appearance rate of 24 to 36 hours and the
disappearance rate between 48 and 72 hours previously
described in healthy individuals [21]. The dye appearance
time was about 1.5 hours shorter when cocoa product B
was consumed compared to the non-cocoa stage, while
the disappearance time was 4 hours shorter. However
these differences did not reach the level of statistical signif-
icance. These effects may be attributed to the higher con-
tent of water insoluble forms of NSP in cocoa product B
(B: 20.3% versus A: 12.0%) which are known to promote
colonic mucosal health through inducing changes such as
increasing faecal bulking or reducing transit time [12,34].
Therefore, the positive self-perceived symptoms previously
described associated to consuming cocoa product B are
supported with objective shorter intestinal transit times,
although not statistically lower.
Surprisingly, product A showed higher dye appearance
and disappearance times compared to the non-cocoa
stage. Regarding these results, it should be noted that very
high intraindividual variance was obtained in the cocoa
product A stage, with abnormally high transit times in
some cases, which is in agreement with the elevated varia-
tion in intestinal transit time described in other studies
[17]. These results may be attributed to other life-style fac-
tors that were not possible to control in this free-living
study. Walking, running, and strength training have been
described to reduce gastrointestinal transit time, [35-37]
although the effectiveness of physical activity in the man-
agement of constipation remains controversial. Recently,
a study performed in normally active subjects, between
24-77 y, failed to prove this relationship [38]. In contrast,
in a group of subjects over 40 years of age, dietary factors
have little influence on defecation habits because of the
stability of large bowel function, and exercise, including
walking, suggested to be more useful in preventing consti-
pation [39]. In this study, the physical activity values are
obtained based on the assumption that 1 MET is approxi-
mately 1 kcal/min may have led to an overestimation of
energy expenditure although this fact is not particularly
relevant as the same factor was used along the study and
physical activity was not different.
As cocoa products are relatively high energy food, in fact
the energy intake was significantly lower (p = 0.045) at the
non-cocoa stage, their addition to a diet could induce
Table 7 Effects of consuming the soluble cocoa products were assessed using a symptom related to bowel habits
questionnaire (Mean values and standard error of mean (SEM), n = 44)
Flatulence Bloating Stool consistency Ease of movement Abdominal Pain
Stage Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Non-cocoa 2.14
a 0.09 1.08 0.11 2.36 0.07 1.15 0.11 0.51 0.08
Cocoa product A 2.07
a 0.14 1.00 0.17 2.36 0.13 1.11 0.16 0.46 0.13
Cocoa product B 2.32
a 0.14 1.11 0.15 2.18 0.10 1.16 0.16 0.52 0.10
p = 0.019 N.S. N.S. N.S. N.S.
A 5-point scale was used to answer where 0 indicates no gas, no bloating, watery stool consistency, easy to pass and no pain, respectively; 5 indicates, severe,
hard or difficult where appropriate. Effects were evaluated using generalized estimating equations with repeated measures (stage) and one fixed factor (cocoa
product) were applied. Where there was a significant main effect, post hoc Bonferroni tests were used to analyse differences between means.
Table 8 Effects of consuming the soluble cocoa products on daily bowel movements was assessed by a daily diary
(mean week values and standard error of mean (SEM), n = 44)
Daily Bowel
movements
Straining at
defecation
Feeling of incomplete and/or difficult
defecation
Lumpy or hard
stools
Stage Mean SEM Mean SEM Mean SEM Mean SEM
Non-cocoa 1.14
a 0.04 0.14 0.02 0.15 0.02 0.28 0.03
Cocoa product A 1.29
b 0.04 0.18 0.02 0.19 0.02 0.32 0.03
Cocoa product B 1.30
b 0.04 0.17 0.02 0.15 0.02 0.27 0.03
p = 0.002 N.S. N.S. p = 0.042
Volunteers were asked to record the number of bowel movements per day and give yes/no responses to the rest of the questions. For statistical purposes, the
conversion of yes = 1 and no = 0 was applied. For all questions the mean was calculated per week.
Effects on daily bowel movements was studied using a mixed model with repeated measures (stage) with one factorial fixed factor (cocoa product). Effects on
straining at defecation, feeling of incomplete and/or difficult defecation and on producing lumpy or hard stools were evaluated using generalized estimating
equations with repeated measures (stage) and one fixed factor (cocoa product) were applied. Where there was a significant main effect, post hoc Bonferroni
tests were used to analyse differences between means.
a, bMean values within a column with unlike superscript values were significantly different according to Bonferroni test.
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Page 8 of 10weight gain. However, the consumption of the cocoa pro-
ducts did not lead to an increase in body weight, without
disregarding the intervention stages were 4 weeks long.
These results are in agreement with previous studies in
humans [40], in which the energy intake was higher in
dark chocolate consumers than in nonconsumers,
although BMI in the former group was lower. The associa-
tion between dark chocolate consumption and lower BMI
has been attributed to the physiologic activity of polyphe-
nols, which have also been described with tea polyphenols
in humans [41]. The mechanisms involved in the antiobe-
sity effects of cocoa have been studied in rats and it seems
that cocoa modulates lipid metabolism, especially by
decreasing fatty acid synthesis and transport systems, and
enhances part of the thermogenesis mechanism in liver
and white adipose tissue [42].
The present study presents certain methodological
limitations: the sample size was calculated according to
total cholesterol, therefore it is not possible to know if
the study was adequately powered, especially after hav-
ing observed that bowel habits show high variability.
Other components of the cocoa products and diet may
have influenced the outcome on bowel habits. Faecal
dyes cannot be quantitated in faeces.
Strengths of the study are that it is the only study that
has used multiple assessments to investigate the effect
of cocoa bran on bowel habits in healthy adults. To our
knowledge, there are only two other human studies that
focus on the same issue, one having been carried out in
constipated children and thus the questionnaires were
answered by their parents [17], and the other uses only
one tool, the symptom diary, to evaluate the effects of
cocoa bran on bowel habits [9]. Moreover, it has been
carried out in 44 subjects which is a relatively high
number compared to similar studies [1,9].
Conclusion
The regular addition of two servings of cocoa products,
providing 2.26 and 6.60 g of total NSP per day, to a
typical Spanish diet is an efficacious alternative to
increase fibre intake to recommended levels without
l e a d i n gt oa ni n c r e a s ei nb o d yw e i g h tw h e nc o n s u m e d
during 4 weeks. Moreover, the cocoa product enriched
with fibre at 22.0% reduces the time to have a bowel
movement and increases the number of daily bowel
movements, without inducing adverse gastrointestinal
symptoms such as abdominal pain or bloating or leading
to having diarrhoea, only flatulence increases. In order
to obtain more accurate information on the effects of
food on bowel habits, it is recommended to use both
subjective self-reported questionnaires as well as objec-
tive measurements.
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